Don S. Dizon

Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Harold J. Burstein, Lada Krilov, Jeanny B. Aragon‐Ching et al. · Journal of Clinical Oncology · 2017 · 599 citations

Cancer Management, Immunology, Pathology +16

A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.

Carol Aghajanian, Steven L. Soignet, Don S. Dizon et al. · PubMed · 2002 · 456 citations

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Alexi A. Wright, Kari Bohlke, Deborah K. Armstrong et al. · Journal of Clinical Oncology · 2016 · 401 citations · Full text

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Alexi A. Wright, Kari Bohlke, Deborah K. Armstrong et al. · Gynecologic Oncology · 2016 · 359 citations · Full text

Neoadjuvant Chemotherapy, Advanced Ovarian Cancer, Medicine +8

Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer

Joyce F. Liu, Christina I. Herold, Kathryn P. Gray et al. · JAMA Oncology · 2019 · 218 citations · Full text